Godsey & Gibb Associates Vivos Therapeutics, Inc. Transaction History

Godsey & Gibb Associates

  • $1.04 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 18, 2023
BUY
$0.32 - $1.88 $29,759 - $174,838
92,999 New
92,999 $31,000

About Vivos Therapeutics, Inc.

VVOS Quotes by TradingView
  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $60.3M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track Godsey & Gibb Associates Portfolio

Follow Godsey & Gibb Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Godsey & Gibb Associates, based on Form 13F filings with the SEC.

News

Stay updated on Godsey & Gibb Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email